Brief: VBI Vaccines Q2 Revenue USD 720 Thousand
14/08/2023 13:00
Aug 14 (Reuters) - VBI Vaccines Q2 net income USD -44.628 million. * Q2 operating income USD -36.972 million * Q2 operating expenses USD 36.579 million
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55